INS and fatty liver disease: Conversely, hepatocyte-specific ChREBP knock-down and knock-out improves hepatic steatosis and insulin signalling in obese mice30 and induces synthesis of cholesterol (as opposed to fatty acids) from intracellular sugars (e.g. fructose)31.